Browse by Sector

Explore NASDAQ stocks by their primary economic sector.

All NASDAQ Stocks Healthcare 892 Financials 884 Information Technology 517 Industrials 386 Consumer Discretionary 320 Communication Services 200 Consumer Staples 114 Materials 78 Energy 67 Real Estate 64 Utilities 27

Industries in Healthcare

Refine the list using the company’s more specific operating industry.

Biotechnology 471 Pharmaceuticals 159 Healthcare Equipment & Supplies 138 Healthcare Providers & Services 61 Life Sciences Tools & Services 38 Health Care Technology 25
Industry stocks

Pharmaceuticals Stocks on NASDAQ

Compare NASDAQ-listed Pharmaceuticals stocks by fair value, valuation, financial quality, profitability, risk, and market outlook.

Pliant Therapeutics Inc (PLRX)
Fair Value35.1% Upside Undervalued Analyst138.1% Upside Market Cap65.016 M P/E-0.6x Yield0.0% HealthFair
  NASDAQ
PolyPid (PYPD)
Fair Value-17.7% Downside Fair Analyst149.0% Upside Market Cap92.803 M P/E-2.8x Yield0.0% HealthFair
  NASDAQ
PRF Technologies Ltd (PRFX)
Fair Value13.6% Upside Fair Market Cap3.164 M P/E-0.7x Yield0.0% HealthWeak
  NASDAQ
Processa Pharmaceuticals Inc (PCSA)
Fair Value-18.5% Downside Overvalued Analyst860.9% Upside Market Cap7.068 M P/E-0.5x Yield0.0% HealthFair
  NASDAQ
Quantum BioPharma Ltd (QNTM)
Fair Value-12.2% Downside Fair Analyst249.1% Upside Market Cap22.078 M P/E-0.7x Yield0.0% HealthWeak
  NASDAQ
Rani Therapeutics Holdings Inc (RANI)
Fair Value42.8% Upside Undervalued Analyst849.4% Upside Market Cap108 M P/E-3.0x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Regencell Bioscience Holdings Ltd (RGC)
Fair Value-44.9% Downside Overvalued Market Cap2.681 B P/E-385.2x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Relmada Therapeutics Inc (RLMD)
Fair Value5.7% Upside Fair Analyst160.4% Upside Market Cap526.9 M P/E-8.3x Yield0.0% HealthFair
  NASDAQ Featured in High-Growth Small-Cap Stocks Small-Cap Stocks
Royalty Pharma Plc (RPRX)
Fair Value-9.8% Downside Fair Analyst10.5% Upside Market Cap32.643 B P/E31.5x Yield1.7% HealthGood
  NASDAQ
Scilex Holding Co (SCLX)
Fair Value33.0% Upside Undervalued Market Cap48.879 M P/E-0.1x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
SNDL Inc (SNDL)
Fair Value59.2% Upside Bargain Analyst187.6% Upside Market Cap305.9 M P/E-19.7x Yield0.0% HealthGood
  NASDAQ Featured in Small-Cap Stocks
Tarsus Pharmaceuticals Inc (TARS)
Fair Value13.2% Upside Fair Analyst47.4% Upside Market Cap2.843 B P/E-61.0x Yield0.0% HealthGreat
  NASDAQ
Tilray Inc (TLRY)
Fair Value47.8% Upside Undervalued Analyst74.9% Upside Market Cap619.8 M P/E-5.0x Yield0.0% HealthFair
  NASDAQ Featured in Small-Cap Stocks
Trevi Therapeutics Inc (TRVI)
Fair Value-40.4% Downside Overvalued Analyst54.9% Upside Market Cap2.637 B P/E-51.4x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks High-Momentum Stocks High-Beta Momentum
Universe Pharmaceuticals Inc (UPC)
Market Cap3.621 M P/E-2.0x Yield0.0% HealthWeak
  NASDAQ
Verrica Pharmaceuticals Inc (VRCA)
Fair Value25.4% Upside Undervalued Analyst187.9% Upside Market Cap87.268 M P/E-2.8x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Vyome Holdings Inc (HIND)
Fair Value-13.5% Downside Fair Analyst418.0% Upside Market Cap15.16 M P/E-1.4x Yield0.0% HealthWeak
  NASDAQ
Xeris Pharmaceuticals Inc (XERS)
Fair Value-9.7% Downside Fair Analyst42.0% Upside Market Cap1.446 B P/E-83.4x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth High-Beta Stocks High-Beta Momentum High-Growth Small-Cap Stocks Small-Cap Stocks
60 Degrees Pharmaceuticals, Inc. (SXTP)
Analyst230.4% Upside Market Cap2.978 M Yield0.0% HealthWeak
  NASDAQ
Aardvark Therapeutics Inc (AARD)
Fair Value20.6% Upside Undervalued Analyst93.9% Upside Market Cap172.3 M P/E-2.4x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Agomab Therapeutics Nv (AGMB)
Fair Value-17.3% Downside Fair Analyst119.6% Upside Market Cap714.1 M P/E-7.8x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
Akanda Corp (AKAN)
Fair Value-9.3% Downside Fair Market Cap4.03 M P/E-0.1x Yield0.0% HealthWeak
  NASDAQ
Alumis Inc (ALMS)
Fair Value-21.0% Downside Overvalued Analyst46.9% Upside Market Cap3.519 B P/E-14.6x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Amylyx Pharmaceuticals Inc (AMLX)
Fair Value-28.2% Downside Overvalued Analyst25.5% Upside Market Cap2.543 B P/E-16.2x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
AN2 Therapeutics Inc (ANTX)
Fair Value-29.9% Downside Overvalued Analyst55.2% Upside Market Cap213.6 M P/E-6.2x Yield0.0% HealthGreat
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks
Aspire Biopharma Holdings Inc (ASBP)
Market Cap10.012 M P/E-0.8x Yield0.0% HealthWeak
  NASDAQ
Belite Bio Inc ADR (BLTE)
Fair Value8.0% Upside Fair Analyst25.8% Upside Market Cap6.414 B P/E-72.2x Yield0.0% HealthFair
  NASDAQ
Bioage Labs Inc (BIOA)
Fair Value-15.0% Downside Fair Analyst209.0% Upside Market Cap537.9 M P/E-5.5x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks Small-Cap Stocks
Biofrontera Inc (BFRI)
Fair Value-4.0% Downside Fair Analyst370.8% Upside Market Cap16.26 M P/E-1.4x Yield0.0% HealthGood
  NASDAQ
Biote Corp (BTMD)
Fair Value24.6% Upside Undervalued Analyst76.1% Upside Market Cap52.619 M P/E7.8x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks High-Beta Momentum
Cadrenal Therapeutics Inc (CVKD)
Fair Value8.6% Upside Fair Analyst601.8% Upside Market Cap5.593 M P/E-0.5x Yield0.0% HealthWeak
  NASDAQ
Cingulate Inc (CING)
Fair Value-13.3% Downside Fair Analyst340.6% Upside Market Cap71.925 M P/E-2.6x Yield0.0% HealthFair
  NASDAQ
Clearmind Medicine Inc (CMND)
Fair Value49.0% Upside Undervalued Market Cap2.421 M P/E-0.3x Yield0.0% HealthWeak
  NASDAQ
Cognition Therapeutics Inc (CGTX)
Fair Value-9.3% Downside Fair Analyst213.0% Upside Market Cap96.658 M P/E-5.7x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Contineum Therapeutics Inc (CTNM)
Fair Value-8.2% Downside Fair Analyst55.7% Upside Market Cap565.8 M P/E-9.4x Yield0.0% HealthFair
  NASDAQ Featured in Small-Cap Stocks
Curanex Pharmaceuticals Inc (CURX)
Fair Value60.5% Upside Bargain Market Cap5.531 M P/E-0.8x Yield0.0% HealthWeak
  NASDAQ
Gelteq Ltd (GELS)
Fair Value17.9% Upside Fair Market Cap6.239 M P/E-1.3x Yield0.0% HealthFair
  NASDAQ
Incannex Healthcare Ltd ADR (IXHL)
Fair Value24.5% Upside Undervalued Analyst462.2% Upside Market Cap37.748 M P/E-0.8x Yield0.0% HealthWeak
  NASDAQ
Indivior PLC (INDV)
Fair Value18.9% Upside Undervalued Analyst27.2% Upside Market Cap4.581 B P/E12.8x Yield0.0% HealthGood
  NASDAQ
InterCure Ltd (INCR)
Fair Value15.5% Upside Fair Market Cap53.925 M P/E-4.5x Yield0.0% HealthGood
  NASDAQ
Journey Medical Corp (DERM)
Fair Value-20.2% Downside Overvalued Analyst114.3% Upside Market Cap177 M P/E-18.4x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks High-Beta Momentum
Jupiter Neurosciences Inc (JUNS)
Fair Value8.4% Upside Fair Market Cap2.953 M P/E-0.3x Yield0.0% HealthWeak
  NASDAQ
LB Pharmaceuticals Inc (LBRX)
Fair Value-38.7% Downside Overvalued Analyst-1.6% Downside Market Cap1.376 B P/E-34.2x Yield0.0% HealthGreat
  NASDAQ Featured in Overvalued Stocks High-Growth Small-Cap Stocks Small-Cap Stocks
Maze Therapeutics Inc (MAZE)
Fair Value-12.2% Downside Fair Analyst129.9% Upside Market Cap1.586 B P/E-12.5x Yield0.0% HealthFair
  NASDAQ Featured in Small-Cap Stocks
MBX Biosciences Inc (MBX)
Fair Value-9.8% Downside Fair Analyst33.4% Upside Market Cap3.266 B P/E-30.5x Yield0.0% HealthGood
  NASDAQ Featured in High-Beta Stocks High-Momentum Stocks High-Beta Momentum
Mira Pharmaceuticals Inc (MIRA)
Fair Value19.9% Upside Undervalued Market Cap31.096 M P/E-1.0x Yield0.0% HealthWeak
  NASDAQ
Neonc Technologies Holdings Inc (NTHI)
Fair Value-9.1% Downside Fair Analyst355.8% Upside Market Cap90.767 M P/E-2.3x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
NervGen Pharma Corp (NGEN)
Fair Value-29.3% Downside Overvalued Analyst516.5% Upside Market Cap182 M P/E-6.1x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks
Neumora Therapeutics Inc (NMRA)
Fair Value31.1% Upside Undervalued Analyst290.2% Upside Market Cap302 M P/E-1.3x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Polaryx Therapeutics Inc (PLYX)
Fair Value-32.5% Downside Overvalued Analyst268.7% Upside Market Cap107 M P/E-16.4x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks
Explore listed stocks on NASDAQ with company information and fair value data.